US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
- The U.S. Food and Drug Administration approved the first flu vaccine for self-administration on Friday; however, it will not be available for this respiratory virus season.
- This approval provides a second option for those eligible, allowing adults or children with help to take the vaccine at home.
- AstraZeneca plans to distribute the vaccine through a third-party online pharmacy, making it available for next year’s respiratory virus season.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left11Leaning Right4Center50Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
L 17%
C 77%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage